Correlation Between PB Fintech and Akums Drugs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both PB Fintech and Akums Drugs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PB Fintech and Akums Drugs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PB Fintech Limited and Akums Drugs and, you can compare the effects of market volatilities on PB Fintech and Akums Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PB Fintech with a short position of Akums Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of PB Fintech and Akums Drugs.

Diversification Opportunities for PB Fintech and Akums Drugs

-0.17
  Correlation Coefficient

Good diversification

The 3 months correlation between POLICYBZR and Akums is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding PB Fintech Limited and Akums Drugs and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akums Drugs and PB Fintech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PB Fintech Limited are associated (or correlated) with Akums Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akums Drugs has no effect on the direction of PB Fintech i.e., PB Fintech and Akums Drugs go up and down completely randomly.

Pair Corralation between PB Fintech and Akums Drugs

Assuming the 90 days trading horizon PB Fintech Limited is expected to generate 0.56 times more return on investment than Akums Drugs. However, PB Fintech Limited is 1.78 times less risky than Akums Drugs. It trades about 0.22 of its potential returns per unit of risk. Akums Drugs and is currently generating about -0.35 per unit of risk. If you would invest  170,115  in PB Fintech Limited on September 2, 2024 and sell it today you would earn a total of  19,275  from holding PB Fintech Limited or generate 11.33% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

PB Fintech Limited  vs.  Akums Drugs and

 Performance 
       Timeline  
PB Fintech Limited 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in PB Fintech Limited are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat inconsistent fundamental drivers, PB Fintech may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Akums Drugs 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Akums Drugs and has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

PB Fintech and Akums Drugs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with PB Fintech and Akums Drugs

The main advantage of trading using opposite PB Fintech and Akums Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PB Fintech position performs unexpectedly, Akums Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akums Drugs will offset losses from the drop in Akums Drugs' long position.
The idea behind PB Fintech Limited and Akums Drugs and pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account